Literature DB >> 28412603

Impairments of balance, stepping reactions and gait in people with cervical dystonia.

Christopher Barr1, Rhiannon Barnard2, Lauren Edwards2, Sheila Lennon2, Lynley Bradnam3.   

Abstract

BACKGROUND: Impaired balance is common in neurological disorders. Cervical dystonia is a neurological movement disorder affecting the neck. The effect of this aberrant head posture on physical function is unknown.
OBJECTIVES: To compare balance, mobility, gait and stepping reactions between ten people with cervical dystonia and ten control adults.
METHODS: Spatiotemporal gait parameters and walking speed were assessed using a computerised walkway. Step length and time, time in double support and gait variability were calculated, then normalised to gait speed. Centre of pressure path length was assessed with eyes open and eyes closed to calculate a Romberg Quotient. Simple and choice reaction times were measured using customised apparatus while mobility was assessed by the timed up and go. Cervical spine range of motion was measured using a head mounted goniometer. Self-reported scales included Falls Self Efficacy Scale and Dystonia Discomfort Scale.
RESULTS: There was a difference between groups for most outcome measures. The timed up-and-go and walking speed was slower (both P<0.005) and the Romberg Quotient lower (P=0.046) in cervical dystonia. People with cervical dystonia had lower falls self-efficacy (P=0.0002). Reduced cervical range of motion was correlated with balance, stepping reaction time and mobility (all P<0.05). Timed up and go was positively associated with stepping reaction time (P<0.01). Dystonia discomfort did not impact function.
CONCLUSIONS: People with cervical dystonia displayed deficits in balance, gait and stepping reactions, and expressed higher fear of falling. Studies to further elucidate functional limitations and their impact on activity and participation in daily life are required.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Balance; Cervical dystonia; Function; Gait; Stepping reactions

Mesh:

Year:  2017        PMID: 28412603     DOI: 10.1016/j.gaitpost.2017.04.004

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  7 in total

1.  A cross-sectional study of walking, balance and upper limb assessment scales in people with cervical dystonia.

Authors:  M J Boyce; A B McCambridge; L V Bradnam; C G Canning; N Mahant; F C F Chang; V S C Fung; A P Verhagen
Journal:  J Neural Transm (Vienna)       Date:  2021-07-31       Impact factor: 3.575

Review 2.  The Anatomical Basis for Dystonia: The Motor Network Model.

Authors:  H A Jinnah; Vladimir Neychev; Ellen J Hess
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-10-23

3.  Decreased postural control in people with moderate hearing loss.

Authors:  Ewan Thomas; Francesco Martines; Antonino Bianco; Giuseppe Messina; Valerio Giustino; Daniele Zangla; Angelo Iovane; Antonio Palma
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

4.  Perception of musculoskeletal pain in the state of confinement: associated factors.

Authors:  Carlos Carpintero-Rubio; Bárbara Torres-Chica; María Alexandra Guadrón-Romero; Laura Visiers-Jiménez; David Peña-Otero
Journal:  Rev Lat Am Enfermagem       Date:  2021-06-28

Review 5.  Neurorehabilitation in dystonia: a holistic perspective.

Authors:  Lynley V Bradnam; Rebecca M Meiring; Melani Boyce; Alana McCambridge
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

6.  The influence of occlusal stabilization appliances on cervical dystonia symptoms.

Authors:  Camelia Navrotchi; Mîndra Eugenia Badea
Journal:  Clujul Med       Date:  2017-10-20

7.  Dual task gait deteriorates gait performance in cervical dystonia patients: a pilot study.

Authors:  Oscar Crisafulli; Carlo Trompetto; Luca Puce; Lucio Marinelli; Stefania Costi; Giovanni Abbruzzese; Laura Avanzino; Elisa Pelosin
Journal:  J Neural Transm (Vienna)       Date:  2021-07-29       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.